Konica Minolta, Healthcare, Q4 2020 Sales Results

On February 2nd, Konica Minolta announced it’s financial results for Q4 2020. Due to the companies reporting cycle, this is its third fiscal quarter. These provide some insight into the sales performance of its healthcare business. During the quarter, sales originating from the healthcare business returned to growth following three consecutive quarters of sales decline. Quarterly sales reached ¥28.1 bn, compared with ¥25.8 bn during Q4 2019, an increase of approximately +9% year-on-year. This took cumulative 2020 sales to ¥88.4 bn, compared with ¥100.6 bn during 2019, a decrease of approximately -12% year-on-year.

The return to sales growth during the quarter was driven by higher demand for digital radiography (DR) and diagnostic ultrasound imaging systems as well as increased demand for IT services. The sales volume of DR equipment was approximately +6% higher year-on-year, driven by strong demand from hospitals in Japan. Overseas sales of dynamic x-ray systems were strong in America as well as China driven by new product releases. On a volume basis, sales of diagnostic ultrasound systems returned to growth during the quarter, supported by an increase in obstetrics sales in Japan, as well as an expansion within China and other parts of Asia.

The Medical IT Segment

Sales of the Acies Picture Archiving and Communication System (PACS) were “slow” in the United States, driven by a restricted sales environment due to the COVID-19 pandemic. On the other hand, sales of “Informity,” an IT service supporting medical image management and collaboration between medical institutions, continued to grow steadily in Japan.

Recent developments within X-ray
Recent developments within ultrasound

Receive sales results directly to your inbox:

Processing…
Success! You're on the list.